Dallas’ Health Wildcatters Second Class of Startups Raises $4.5M

The Health Wildcatters accelerator in Dallas says its second class of startups have raised $4.5 million since leaving the program in November.

Silicone Arts Laboratories, which makes a synthetic skin product, received the most of the companies, closing on a $1.5 million Series A round last month. Tennessee-based Innova was the lead investor and Green Park & Golf Ventures in Dallas also participated.

Other companies in the class that raised funds included Lantern Pharma, which is developing a drug candidate for ovarian and prostate cancers, with $960,000 from Green Park & Golf; and Orb Health, which raised $650,000.

Lucy Soderberg, a spokeswoman for the accelerator, says that the inaugural cohort of Health Wildcatters companies raised slightly more, $4.6 million.

Health Wildcatters will host its third class of healthcare-related startups this fall in the 12-week accelerator program.

Author: Angela Shah

Angela Shah was formerly the editor of Xconomy Texas. She has written about startups along a wide entrepreneurial spectrum, from Silicon Valley transplants to Austin transforming a once-sleepy university town in the '90s tech boom to 20-something women defying cultural norms as they seek to build vital IT infrastructure in a war-torn Afghanistan. As a foreign correspondent based in Dubai, her work appeared in The New York Times, TIME, Newsweek/Daily Beast and Forbes Asia. Before moving overseas, Shah was a staff writer and columnist with The Dallas Morning News and the Austin American-Statesman. She has a Bachelor's of Journalism from the University of Texas at Austin, and she is a 2007 Knight-Wallace Fellow at the University of Michigan. With the launch of Xconomy Texas, she's returned to her hometown of Houston.